Nexsun Diagnostic Laboratories LLC

Nexsun Diagnostic Laboratories LLC was paid $171K by Medicaid between May 2022 and Oct 2024, across 18 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 62% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#293 of 561

Median peer was paid$222K

This provider vs. median0.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	2,464	$86K
2023	972	$39K
2024incomplete	1,939	$46K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	62%	1,952	807	$106K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	1,484	525	$19K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	7.3%	322	230	$13K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	6.4%	133	133	$11K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	4.7%	208	171	$8K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	2.6%	45	45	$4K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.4%	146	145	$2K
87481		1.1%	301	235	$2K
87631		<1%	47	47	$870.79
87500		<1%	184	180	$861.50
87641		<1%	182	176	$763.02
87653		<1%	181	176	$754.06

6 more codes

87581		<1%	39	$491.89
87498		<1%	39	$491.89
87486		<1%	39	$491.89
87541		<1%	39	$491.89
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	17	$229.92
87634		<1%	17	$187.17

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGHAFOOR, SHAKIL (OWNER)